{"category": "Risks & Challenges", "question": "What litigation contingencies were disclosed in the latest 10?_?", "file_type": "10-Q", "index": 2, "relevance_count": 5, "relevance_score": 2, "result_lines": ["3", "See Notes to Consolidated Financial Statements."], "translated_lines": ["연결 재무제표에 대한 참고 사항을 참조하십시오.", "3"], "chunk": "See Notes to Consolidated Financial Statements.\n\n3"}
{"category": "Risks & Challenges", "question": "What litigation contingencies were disclosed in the latest 10?_?", "file_type": "10-Q", "index": 5, "relevance_count": 5, "relevance_score": 2, "result_lines": ["4", "See Notes to Consolidated Financial Statements."], "translated_lines": ["연결 재무제표에 대한 참고 사항을 참조하십시오.", "4"], "chunk": "See Notes to Consolidated Financial Statements.\n\n4"}
{"category": "Risks & Challenges", "question": "What litigation contingencies were disclosed in the latest 10?_?", "file_type": "10-Q", "index": 8, "relevance_count": 5, "relevance_score": 2, "result_lines": ["See Notes to Consolidated Financial Statements.", "5"], "translated_lines": ["연결 재무제표에 대한 참고 사항을 참조하십시오.", "5"], "chunk": "See Notes to Consolidated Financial Statements.\n\n5"}
{"category": "Risks & Challenges", "question": "What litigation contingencies were disclosed in the latest 10?_?", "file_type": "10-Q", "index": 11, "relevance_count": 5, "relevance_score": 2, "result_lines": ["6", "See Notes to Consolidated Financial Statements."], "translated_lines": ["6", "연결 재무제표에 대한 참고 사항을 참조하십시오."], "chunk": "See Notes to Consolidated Financial Statements.\n\n6"}
{"category": "Risks & Challenges", "question": "What litigation contingencies were disclosed in the latest 10?_?", "file_type": "10-Q", "index": 14, "relevance_count": 5, "relevance_score": 2, "result_lines": ["See Notes to Consolidated Financial Statements.", "7"], "translated_lines": ["연결 재무제표에 대한 참고 사항을 참조하십시오.", "7"], "chunk": "See Notes to Consolidated Financial Statements.\n\n\n\n\n\n\n\n7"}
{"category": "Risks & Challenges", "question": "What litigation contingencies were disclosed in the latest 10?_?", "file_type": "10-Q", "index": 17, "relevance_count": 5, "relevance_score": 2, "result_lines": ["8", "See Notes to Consolidated Financial Statements."], "translated_lines": ["8", "연결 재무제표에 대한 참고 사항을 참조하십시오."], "chunk": "See Notes to Consolidated Financial Statements.\n\n\n\n8"}
{"category": "Risks & Challenges", "question": "What litigation contingencies were disclosed in the latest 10?_?", "file_type": "10-Q", "index": 19, "relevance_count": 5, "relevance_score": 2, "result_lines": ["Note 14##Commitments and Contingencies##25", "Note 13##Earnings per Share##25", "Note 15##Segment Reporting##25"], "translated_lines": ["참고 14##약속 및 우발 상황##25", "참고 15##세그먼트 보고##25", "주당순이익 13##Earnings per Share##25", "주당순이익"], "chunk": "Note 1##Summary of Significant Accounting Policies and Estimates##10\nNote 2##Acquisitions, Divestitures and Strategic Alliance##10\nNote 3##Derivative Financial Instruments##11\nNote 4##Fair Value Measurements##15\nNote 5##Inventories##17\nNote 6##Supplemental Balance Sheet and Statement of Earnings Information##17\nNote 7##Other Intangible Assets and Goodwill##18\nNote 8##Debt##19\nNote 9##Leases##21\nNote 10##Deferred Revenue##22\nNote 11##Equity##23\nNote 12##Employee Stock Plans##24\nNote 13##Earnings per Share##25\nNote 14##Commitments and Contingencies##25\nNote 15##Segment Reporting##25"}
{"category": "Risks & Challenges", "question": "What litigation contingencies were disclosed in the latest 10?_?", "file_type": "10-Q", "index": 23, "relevance_count": 5, "relevance_score": 2, "result_lines": ["Gains and losses on derivative contracts and foreign currency-denominated debt designated as hedging instruments included in AOCI and expected to be reclassified into earnings within 12 months, net of tax (in millions):"], "translated_lines": ["파생상품 계약 및 환율 표시 부채에 대한 손익은 헤지 수단으로 지정되어 있으며, 세후 순액으로 12개월 이내에 손익계산서로 재분류될 것으로 예상되는 AOCI에 포함됩니다 (백만 단위).", "파생상품 계약 및 환율 표시 부채에 대한 손익은 헤지 수단으로 지정되어 있으며, 세후 순액으로 12개월 이내에 손익계산서로 재분류될 것으로 예상되는 AOCI에 포함됩니다(백만 단위)."], "chunk": "Gains and losses on derivative contracts and foreign currency-denominated debt designated as hedging instruments included in AOCI and expected to be reclassified into earnings within 12 months, net of tax (in millions):"}
{"category": "Risks & Challenges", "question": "What litigation contingencies were disclosed in the latest 10?_?", "file_type": "10-Q", "index": 25, "relevance_count": 5, "relevance_score": 2, "result_lines": ["Pre-tax gains and losses on derivative contracts and foreign currency-denominated long-term debt designated as hedging instruments recognized in other comprehensive income (“OCI”) and reclassifications from AOCI to earnings (in millions):"], "translated_lines": ["파생상품 계약 및 외화 표시 장기 채무에 대한 세전 손익(헤지 수단으로 지정된 경우)과 기타포괄손익(OCI)에서 인식된 재분류(기타포괄손익에서 손익으로의 재분류)(백만 단위):", "파생상품 계약에 대한 세전 손익과 헤지수단으로 지정된 외화 표시 장기채무의 기타포괄손익(OCI) 인식 및 AOCI에서 손익으로의 재분류(백만 단위):"], "chunk": "Pre-tax gains and losses on derivative contracts and foreign currency-denominated long-term debt designated as hedging instruments recognized in other comprehensive income (“OCI”) and reclassifications from AOCI to earnings (in millions):"}
{"category": "Risks & Challenges", "question": "What litigation contingencies were disclosed in the latest 10?_?", "file_type": "10-Q", "index": 28, "relevance_count": 5, "relevance_score": 2, "result_lines": ["Pre-tax gains and losses on non-designated derivatives and designated fair value hedging instruments and the related fair value hedged item recognized in earnings (in millions):"], "translated_lines": ["비지정 파생상품 및 지정 공정가치 헤지 수단과 관련 공정가치 헤지 대상이 손익에 인식된 세전 손익(백만 단위):", "비지정 파생상품 및 지정된 공정가치 헤지 수단과 관련 공정가치 헤지 대상이 손익에 인식된 세전 손익(백만 단위):"], "chunk": "Pre-tax gains and losses on non-designated derivatives and designated fair value hedging instruments and the related fair value hedged item recognized in earnings (in millions):"}
{"category": "Risks & Challenges", "question": "What litigation contingencies were disclosed in the latest 10?_?", "file_type": "10-Q", "index": 37, "relevance_count": 5, "relevance_score": 2, "result_lines": ["14", "Additional disclosures related to cash flow gains and losses included in AOCI, as well as subsequent reclassifications to earnings, are included in Note 11, Equity."], "translated_lines": ["14", "현금 흐름 손익과 관련된 추가 공시 사항은 AOCI에 포함되어 있으며, 이후 손익으로 재분류되는 내용은 주석 11, 자본에 포함되어 있습니다.", "현금 흐름 손익과 관련된 추가 공시 사항은 AOCI에 포함되어 있으며, 이후 손익으로 재분류된 내용도 11번 주석(자본)에 포함되어 있습니다.", "현금 흐름 손익과 관련된 추가 공시 사항은 AOCI에 포함되어 있으며, 이후 손익으로 재분류된 내용도 Note 11, 자본에 포함되어 있습니다."], "chunk": "Additional disclosures related to cash flow gains and losses included in AOCI, as well as subsequent reclassifications to earnings, are included in Note 11, Equity.\n\n14"}
{"category": "Risks & Challenges", "question": "What litigation contingencies were disclosed in the latest 10?_?", "file_type": "10-Q", "index": 45, "relevance_count": 4, "relevance_score": 1, "result_lines": ["A portion of our price-to-be-fixed contracts are effectively fixed through the use of futures.", "See Note 3, Derivative Financial Instruments, for further discussion.", "Price-to-be-fixed contracts are purchase commitments whereby the quality, quantity, delivery period and other negotiated terms are agreed upon, but the date, and therefore the price, at which the base “C” coffee commodity price component will be fixed has not yet been established."], "translated_lines": ["가격이 확정되지 않은 계약은 품질, 수량, 납기 기간 및 기타 협상된 조건들이 합의되었지만, 기준 \"C\" 커피 상품 가격 구성요소의 가격이 확정될 날짜, 즉 가격이 정해질 시점이 아직 정해지지 않은 구매 약속입니다.", "우리의 고정 가격 계약 일부는 선물을 이용하여 사실상 고정되어 있습니다.", "고정될 가격 계약은 품질, 수량, 납기 기간 및 기타 협상된 조건이 합의된 구매 약속이지만, 기준 \"C\" 커피 상품 가격 구성요소의 가격이 고정될 날짜, 즉 가격이 아직 정해지지 않은 계약입니다.", "자세한 내용은 참고 3, 파생 금융 상품을 참조하십시오.", "고정될 가격 계약은 품질, 수량, 납기 기간 및 기타 협상된 조건이 합의된 구매 약속이지만, 기준 \"C\" 커피 상품 가격 구성요소의 가격이 확정될 날짜, 즉 가격이 아직 정해지지 않은 계약입니다."], "chunk": "Other merchandise held for sale includes, among other items, serveware, food and tea. Inventory levels vary due to seasonality, commodity market supply and price fluctuations.\n\nAs of July 2, 2023, we had committed to purchasing green coffee totaling $300.5 million under fixed-price contracts and an estimated $786.0 million under price-to-be-fixed contracts. A portion of our price-to-be-fixed contracts are effectively fixed through the use of futures. See Note 3, Derivative Financial Instruments, for further discussion. Price-to-be-fixed contracts are purchase commitments whereby the quality, quantity, delivery period and other negotiated terms are agreed upon, but the date, and therefore the price, at which the base “C” coffee commodity price component will be fixed has not yet been established. For most contracts, either Starbucks or the seller has the option to “fix” the base “C” coffee commodity price prior to the delivery date. For other contracts, Starbucks and the seller may agree upon pricing parameters determined by the base “C” coffee commodity price. Until prices are fixed, we estimate the total cost of these purchase commitments. We believe, based on established relationships with our suppliers and continuous monitoring, the risk of non-delivery on these purchase commitments is remote.\n\nNote 6: Supplemental Balance Sheet and Statement of Earnings Information (in millions):\n\nProperty, Plant and Equipment, net"}
{"category": "Risks & Challenges", "question": "What litigation contingencies were disclosed in the latest 10?_?", "file_type": "10-Q", "index": 47, "relevance_count": 5, "relevance_score": 2, "result_lines": ["Accrued Liabilities"], "translated_lines": ["누적 부채"], "chunk": "Accrued Liabilities"}
{"category": "Risks & Challenges", "question": "What litigation contingencies were disclosed in the latest 10?_?", "file_type": "10-Q", "index": 58, "relevance_count": 4, "relevance_score": 1, "result_lines": ["Goodwill", "Changes in the carrying amount of goodwill by reportable operating segment (in millions):"], "translated_lines": ["보고 가능 영업 부문별 영업권 장부금액 변동(백만 단위):", "선의", "호의", "영업권"], "chunk": "Goodwill\n\nChanges in the carrying amount of goodwill by reportable operating segment (in millions):"}
{"category": "Risks & Challenges", "question": "What litigation contingencies were disclosed in the latest 10?_?", "file_type": "10-Q", "index": 71, "relevance_count": 5, "relevance_score": 2, "result_lines": ["There were no material finance leases as of July 2, 2023 and October 2, 2022.", "Minimum future maturities of operating lease liabilities (in millions):"], "translated_lines": ["운영 임대 부채의 최소 만기일 (백만 단위):", "2023년 7월 2일과 2022년 10월 2일 현재 재무 임대료는 없었습니다.", "2023년 7월 2일과 2022년 10월 2일 현재 재무 임대는 없었습니다."], "chunk": "Finance lease assets are recorded in property, plant and equipment, net with the corresponding lease liabilities included in accrued liabilities and other long-term liabilities on the consolidated balance sheet. There were no material finance leases as of July 2, 2023 and October 2, 2022.\n\nMinimum future maturities of operating lease liabilities (in millions):"}
{"category": "Risks & Challenges", "question": "What litigation contingencies were disclosed in the latest 10?_?", "file_type": "10-Q", "index": 89, "relevance_count": 5, "relevance_score": 2, "result_lines": ["Note 14: Commitments and Contingencies", "Legal Proceedings", "Note 15: Segment Reporting", "Starbucks is involved in various legal proceedings arising in the ordinary course of business, including certain employment litigation cases that have been certified as class or collective actions, but is not currently a party to any legal proceeding that management believes could have a material adverse effect on our consolidated financial position, results of operations or cash flows.", "The calculation of dilutive shares outstanding excludes anti-dilutive stock options or unvested RSUs, which were immaterial in the periods presented."], "translated_lines": ["참고 14: 약속 및 우발 상황", "희석 주식수 계산에는 희석 효과가 없는 주식 옵션 또는 미취득 RSU가 제외되며, 이는 제시된 기간 동안 중요하지 않았습니다.", "참고 14: 약속 및 우발사건", "스타벅스는 일반적인 업무 과정에서 발생하는 다양한 법적 절차에 관여하고 있으며, 일부 고용 관련 소송 사건이 집단 또는 집단 소송으로 인증되었지만, 현재 경영진이 우리의 연결 재무 상태, 영업 실적 또는 현금 흐름에 중대한 부정적 영향을 미칠 수 있다고 믿는 법적 절차에는 참여하고 있지 않습니다.", "법적 절차", "참고 15: 세그먼트 보고"], "chunk": "Potential dilutive shares consist of the incremental common shares issuable upon the exercise of outstanding stock options (both vested and non-vested) and unvested RSUs, calculated using the treasury stock method. The calculation of dilutive shares outstanding excludes anti-dilutive stock options or unvested RSUs, which were immaterial in the periods presented.\n\nNote 14: Commitments and Contingencies\n\nLegal Proceedings\n\nStarbucks is involved in various legal proceedings arising in the ordinary course of business, including certain employment litigation cases that have been certified as class or collective actions, but is not currently a party to any legal proceeding that management believes could have a material adverse effect on our consolidated financial position, results of operations or cash flows.\n\nNote 15: Segment Reporting\n\nSegment information is prepared on the same basis that our chief executive officer, who is our chief operating decision maker, manages the segments, evaluates financial results and makes key operating decisions.\n\nConsolidated revenue mix by product type (in millions):"}
{"category": "Risks & Challenges", "question": "What litigation contingencies were disclosed in the latest 10?_?", "file_type": "10-Q", "index": 124, "relevance_count": 5, "relevance_score": 2, "result_lines": ["Item 1.Legal Proceedings", "See Note 14, Commitments and Contingencies, to the consolidated financial statements included in Item 1 of Part I of this 10-Q for information regarding certain legal proceedings in which we are involved.", "Item 1A.Risk Factors"], "translated_lines": ["항목 1. 법적 절차", "당사의 법적 절차에 관한 정보는 이 10-Q의 Part I의 Item 1에 포함된 통합 재무제표의 참고 14, 약속 및 우발상황을 참조하십시오.", "항목 1A. 위험 요인", "당사와 관련된 특정 법적 절차에 관한 정보는 이 10-Q의 Part I의 Item 1에 포함된 통합 재무제표의 참고 14, 약속 및 우발상황을 참조하십시오.", "당사의 법적 절차에 관한 자세한 내용은 이 10-Q의 Part I의 Item 1에 포함된 연결 재무제표의 참고 14, 약속 및 우발채무를 참조하십시오.", "당사의 법적 절차와 관련된 특정 법적 소송에 관한 정보는 이 10-Q의 Part I의 Item 1에 포함된 통합 재무제표의 참고 14, 약속 및 우발상황을 참조하십시오."], "chunk": "PART II — OTHER INFORMATION\n\nItem 1.Legal Proceedings\n\nSee Note 14, Commitments and Contingencies, to the consolidated financial statements included in Item 1 of Part I of this 10-Q for information regarding certain legal proceedings in which we are involved.\n\nItem 1A.Risk Factors\n\nIn addition to the other information set forth in this 10-Q, you should carefully consider the risks and uncertainties discussed in Part I, Item 1A. Risk Factors in our 10-K and Part II, Item 1A. There have been no material changes to the risk factors disclosed in our 10-K.\n\nItem 2.Unregistered Sales of Equity Securities and Use of Proceeds\n\nInformation regarding repurchases of our common stock during the quarter ended July 2, 2023:"}
